ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: "SurModics, Inc." (SRDX) Report Updated: Nov 24, 2014 | Print This Page

Get more stock ratings by Louis Navellier

"SurModics, Inc." (SRDX)

Rating: Hold Volatility: Conservative
Total Grade: C Industry: Health Care Equipment & Supplies
Competitors: ZLTQ, NXTM, BABY, ABAX

Stock Analysis

Rating: Monthly View

A
B
C
D
F
November December January February March April May June July August September October

Rating: Weekly View

This Week: C down upgrade
Last Week: D same no change
Two Weeks Ago: D up no change
service keys

"SurModics, Inc."© quotemedia

Company Profile

SurModics, Inc. provides drug delivery and surface modification technologies to the healthcare industry. The company offers surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device for the coronary, peripheral, neuro-vascular, and urology markets. It also provides a range of drug delivery technologies for injectable therapeutics, including microparticles, nanoparticles, and implants addressing a range of clinical applications, such as ophthalmology, oncology, dermatology, and neurology. In addition, the company provides in vitro diagnostic component products and technologies comprising microarray slide technologies, protein stabilization reagents, substrates, polymers and reagent chemicals, and antigens for diagnostic test kits and biomedical research applications. SurModics, Inc. markets its technologies and products worldwide through direct sales force consisting of sales professionals. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

Recent News: "SurModics, Inc."